Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Invested Capital: 2017-2019

Historic Invested Capital for Astria Therapeutics (ATXS) over the last 3 years, with Sep 2019 value amounting to $38.3 million.

  • Astria Therapeutics' Invested Capital fell 5.54% to $38.3 million in Q3 2019 from the same period last year, while for Sep 2019 it was $38.3 million, marking a year-over-year decrease of 5.54%. This contributed to the annual value of $34.9 million for FY2018, which is 196.32% up from last year.
  • According to the latest figures from Q3 2019, Astria Therapeutics' Invested Capital is $38.3 million, which was down 11.73% from $43.4 million recorded in Q2 2019.
  • Over the past 5 years, Astria Therapeutics' Invested Capital peaked at $49.9 million during Q1 2019, and registered a low of $11.8 million during Q4 2017.
  • In the last 3 years, Astria Therapeutics' Invested Capital had a median value of $34.9 million in 2018 and averaged $30.8 million.
  • Per our database at Business Quant, Astria Therapeutics' Invested Capital plummeted by 46.02% in 2018 and then skyrocketed by 285.65% in 2019.
  • Quarterly analysis of 3 years shows Astria Therapeutics' Invested Capital stood at $11.8 million in 2017, then soared by 196.32% to $34.9 million in 2018, then fell by 5.54% to $38.3 million in 2019.
  • Its Invested Capital was $38.3 million in Q3 2019, compared to $43.4 million in Q2 2019 and $49.9 million in Q1 2019.